Mark T Reding

Active

A MULTICENTER NON-INTERVENTIONAL STUDYEVALUATING BLEEDS AND HEALTH-REATEDQUALITY OF LIFE IN PATIENTS WITH TYPE 3VON WILLEBRAND DISEASE ON PROPHYLACTICSTANDARD-OF-CARE TREATMENT

Reding, M. T. (PI)

HOFFMANN-LA ROCHE PHARMACEUTICALS

2/18/25 → 2/17/36

Project: Research project

A PHASE III, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH TYPE 3 VON WILLEBRAND DISEASE

Reding, M. T. (PI)

HOFFMANN-LA ROCHE PHARMACEUTICALS

2/5/25 → 2/4/36

Project: Research project

A Phase 1/2 Dose Escalation and Expansion Study of BE-101 forthe Treatment of Adults with Moderately Severe or Severe Hemophilia BA Phase 1/2 Dose Escalation and Expansion Study of BE-101 for...

Reding, M. T. (PI)

BE BIOPHARMA, INC

10/15/24 → 6/9/35

Project: Research project

A Global, Open-label Study to Investigate the Efficacy and Safety ofSerpinPC in Subjects With Hemophilia B With Inhibitors

Reding, M. T. (PI)

APCINTEX LIMITED

10/15/24 → 10/14/35

Project: Research project

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction (PH-HFpEF)

Thenappan, T. (PI) & Reding, M. T. (Prior Principal Investigator)

TENAX THERAPEUTICS, INC

3/20/24 → 3/19/33

Project: Research project

A Global, Open-label, Adaptive Design Study to Investigate the Efficacy andSafety of SerpinPC in Subjects With Severe Hemophilia A or Moderately Severe to SevereHemophilia B

Reding, M. T. (PI)

APCINTEX LIMITED

10/3/23 → 12/13/25

Project: Research project

A Phase 3, single-arm, open-label, multicenter study of the safety and efficacy of dirloctocogene samoparvovec (SPK-8011, adeno-associated viral vector with B-domain deleted human factor VIII gene) in adults with severe or moderately severe hemophili

Reding, M. T. (PI)

SPARK THERAPEUTICS, INC

9/22/23 → 9/30/33

Project: Research project

ADVANCECardiovascular Disease (CVD)

Reding, M. T. (PI)

INDIANA HEMOPHILIA AND THROMBOSIS CENTER, BAYER HEALTHCARE PHARMACEUTICALS

8/23/23 → 6/30/27

Project: Research project

A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII in Hemophilia A Patients with Residual FVIII Levels...

Reding, M. T. (PI)

BIOMARIN PHARMACEUTICAL, INC.

5/1/18 → 7/31/25

Project: Research project

Public Health Surveillance for the Prevention of Complic

Reding, M. T. (PI)

FAIRVIEW HEALTH SERVICES, GREAT LAKES HEMOPHILIA FDN

9/30/11 → 9/29/25

Project: Research project

Finished

A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector Mediated Gene Transfer of Human Factor VIII at a dose of 4E13 vg/kg inHemophilia A Patients with Residual FVIII Levels

Reding, M. T. (PI)

BIOMARIN PHARMACEUTICAL, INC.

7/15/18 → 7/15/23

Project: Research project

Health Resources and Services Administration Grant

Reding, M. T. (PI)

FAIRVIEW HEALTH SERVICES, GREAT LAKES HEMOPHILIA FDN

6/1/18 → 5/31/25

Project: Research project

A Prospective Non-Interventional Study of Bleed

Reding, M. T. (PI)

BIOMARIN PHARMACEUTICAL, INC.

2/15/18 → 12/31/23

Project: Research project

Health Resources and Services Administration Grant

Reding, M. T. (PI)

FAIRVIEW HEALTH SERVICES, GREAT LAKES HEMOPHILIA FDN

6/1/17 → 9/29/20

Project: Research project

ECHO: Expanding Communications on Hemophilia-A Outcomes.

Reding, M. T. (PI)

BAYER HEALTHCARE PHARMACEUTICALS

7/1/16 → 12/31/21

Project: Research project

A RANDOMIZED, MULTICENTER, OPEN-LABEL, PHASE III CLINICA

Reding, M. T. (PI)

GENENTECH, INC.

2/1/16 → 7/31/16

Project: Research project

A Phase III Study on the Safety, Pharmacokinetics and Ef

Reding, M. T. (PI)

REVO BIOLOGICS, INC.

6/1/14 → 5/31/18

Project: Research project

My Life Our Future: A Hemophilia Genotyping Initiative D

Reding, M. T. (PI)

AMERICAN THROMBOSIS & HEMOSTATIS NETWORK

11/1/13 → 12/31/18

Project: Research project

An Observational Study of Postoperative Deep Venous Thro

Reding, M. T. (PI)

THE UNIV OF N CAROLINA AT CHAPEL HILL, BAXTER HEALTHCARE CORP

11/5/12 → 4/2/19

Project: Research project

A Phase 1/2 Open-Label, Single Ascending Dose Trial of a

Reding, M. T. (PI)

BAXTER HEALTHCARE CORP

9/17/12 → 12/31/16

Project: Research project

A Phase 1/2 Open-Label, Single Ascending Dose Trial of a

Reding, M. T. (PI)

ASKLEPIOS BIOPHARMACEUTICAL, INC

5/30/12 → 5/30/17

Project: Research project

A Phase II/III, multicenter, partially randomized, open

Reding, M. T. (PI)

BAYER HEALTHCARE PHARMACEUTICALS

4/24/12 → 12/31/18

Project: Research project

Prospective, Open-Label, Multi-Center, Phase III Clinica

Reding, M. T. (PI)

OCTAPHARMA USA, INC.

3/14/12 → 3/13/17

Project: Research project

Pathophysiology of anti-factor VIII inhibitor developmen

Reding, M. T. (PI)

EMORY UNIVERSITY, NATIONAL INSTITUTES OF HEALTH (NIH)

3/8/11 → 2/28/14

Project: Research project

Efficacy and Safety of NNC 0078-0000-0007 in Treatment o

Reding, M. T. (PI)

NOVO NORDISK, INC.

2/28/11 → 2/27/15

Project: Research project

An open-label Phase I trial to evaluate the pharmacokine

Reding, M. T. (PI)

BAYER HEALTHCARE PHARMACEUTICALS

6/1/10 → 5/31/13

Project: Research project

Phase I/II/III Pharmacokinetic and Outcome Study of Insp

Reding, M. T. (PI)

INSPIRATION BIOPHARMACEUTICALS, INC

5/14/10 → 12/31/20

Project: Research project

National Hemophilia Foundation's National Prevention Program

Reding, M. T. (PI)

NATL HEMOPHILIA FDN

10/15/08 → 12/31/10

Project: Research project

Dosing Observational Study In Hemophilia Subjects with I

Reding, M. T. (PI)

Outcome Sciences, Inc., NOVO NORDISK PHARMA INC

2/22/08 → 5/31/10

Project: Research project

Randomized, controlled, parallel, prospective trial to e

Reding, M. T. (PI)

Pharmaceutical Product Development, Inc.

1/1/08 → 12/31/13

Project: Research project

TMH 04: High Dose Granulocyte Transfusions for the Treat

Mc Cullough, J. (PI), Reding, M. T. (CoI) & Steiner, M. E. (CoI)

NEW ENGLAND RESEARCH INSTITUTES, NIH NAT'L HEART, LUNG, AND BLOOD INSTITU

1/1/08 → 12/31/13

Project: Research project

TMH Network Master Site Agreement - HIT Observational Th

Mc Cullough, J. (PI), Reding, M. T. (CoI) & Steiner, M. E. (CoI)

NEW ENGLAND RESEARCH INSTITUTES, NIH NAT'L HEART, LUNG, AND BLOOD INSTITU

9/1/07 → 8/31/12

Project: Research project

Determination of the Optimal Prophylactic Platelet Dose

Mc Cullough, J. (PI), Reding, M. T. (CoI) & Steiner, M. E. (CoI)

NEW ENGLAND RESEARCH INSTITUTES, NIH NAT'L HEART, LUNG, AND BLOOD INSTITU

9/1/07 → 8/31/12

Project: Research project

MASTER: TMH Network Master Site Agreement

Mc Cullough, J. (PI), Clay, M. (CoI), Reding, M. T. (CoI) & Steiner, M. E. (CoI)

NEW ENGLAND RESEARCH INSTITUTES, NIH NAT'L HEART, LUNG, AND BLOOD INSTITU

9/1/07 → 8/31/14

Project: Research project

Clinical Trials in Transfusion Medicine and Hemostasis

Mc Cullough, J. (PI), Clay, M. (CoI) & Reding, M. T. (CoI)

NIH NAT'L HEART, LUNG, AND BLOOD INSTITU

9/1/07 → 8/31/14

Project: Research project

A multi-centre, randomised, double-blinded, controlled,

Reding, M. T. (PI)

NOVO NORDISK, INC.

5/22/07 → 12/31/20

Project: Research project

Strategies to Prevent the Complications of Hemophilia

Reding, M. T. (PI)

GREAT LAKES HEMOPHILIA FDN, CENTERS FOR DISEASE CONTROL & PREVENTION

9/30/06 → 9/29/11

Project: Research project

BOEC and SBTn for Gene Therapy

Hebbel, R. P. (PI), Key, N. (CoI), Kren, B. J. (CoI), Reding, M. T. (CoI) & Steer, C. J. (CoI)

NATL HEMOPHILIA FDN

7/1/06 → 6/30/10

Project: Research project

Advate Antihemophilic Factor (Recombinant), Plasma/Album

Reding, M. T. (PI)

BAXTER HEALTHCARE CORP

2/16/06 → 12/31/09

Project: Research project

Upper Midwest Hemophilia Diagnostic & Treatment Center Health Resources and Services Administration Grant

Reding, M. T. (PI)

FAIRVIEW HEALTH SERVICES, GREAT LAKES HEMOPHILIA FDN

6/1/05 → 5/31/17

Project: Research project

Lonafarnib in CMML (SPRI P-02978)

Reding, M. T. (PI)

SCHERING-PLOUGH CORPORATION

2/17/05 → 7/1/08

Project: Research project

OBI-1 Open Label

Reding, M. T. (PI)

OCTAGEN CORP

2/10/05 → 12/31/07

Project: Research project

Immune response to factor VIII following gene therapy wi

Reding, M. T. (PI)

HEMOPHILIA OF GEORGIA INC

7/1/03 → 6/30/08

Project: Research project

Upper Midwest Hemophilia Diagnostic & Treatment Center

Reding, M. T. (PI)

GREAT LAKES HEMOPHILIA FDN, CENTERS FOR DISEASE CONTROL & PREVENTION

10/1/93 → 9/29/06

Project: Research project

Mark T Reding

Projects

Search results